MedPath

The effect of Saccharomyces bulardii in the eradication of Helicobacter pylori

Phase 3
Conditions
Helicobacter pylori disease.
Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters
Registration Number
IRCT20221025056290N1
Lead Sponsor
Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
152
Inclusion Criteria

People with Helicobacter pylori infection

Exclusion Criteria

History of systematic and standardized eradication treatment
Kidney failure
Taking antibiotics in the last month
The person is pregnant and breastfeeding
history of neurological disease
Weakness in the immune system or taking immunosuppressive drugs

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Helicobacter pylori eradication. Timepoint: After one month of the last dose of antibiotics, and the patients have not taken PPI drugs for at least two week. Method of measurement: Fecal antigen test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath